5/13/22 – Weekly Covid-19 Update

CHAP’s COVID-19 Weekly Update
In this “one-stop-shop” update, CHAP will provide a roundup of important COVID-19 information from various federal sources.

All health care providers should be monitoring COVID-19 incidence rates in their state/county on an ongoing basis.  The Centers for Disease Control and Prevention CDC provides weekly data about case rates, deaths, testing, and vaccine administration on their COVID tracker webpage.


CDC Data

FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals (5/5/22)
The FDA has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved COVID-19 vaccines are not accessible or clinically appropriate and to individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine.


FDA Update
The FDA issued a safety communication warning people to not use the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Test (Colloidal Gold). This test is not authorized, cleared, or approved by the FDA for distribution or use in the United States. The FDA is concerned about the risk of false results when using this test because SML Distribution LLC has not provided the FDA with adequate data to show the tests work correctly. SML Distribution LLC is recalling the Skippack Medical Lab SARS-CoV-2 Antigen Rapid Tests (Colloidal Gold), and the FDA has identified this issue as a Class I recall, the most serious type of recall.


Media Advisory: Second COVID-⁠19 Summit (5/10/22)
The United States as first COVID Summit Chair, Belize as CARICOM Chair; Germany, holding the G7 Presidency; Indonesia, holding the G20 Presidency; and Senegal as African Union Chair, will co-host the second Global COVID-19 Summit, which will be held virtually on Thursday, May 12, 2022.  President Biden and fellow heads of state from the co-host nations will kick off the Summit with remarks on how fighting COVID-19 must remain an international priority. The Summit will then feature three sessions focused on getting shots in arms, expanding access to tests and treatments, advancing health security, and preventing future catastrophes.  Ahead of the Summit, the U.S. called on the leaders of governments, civil society, businesses, and philanthropies to make significant new commitments.